✦ LIBER ✦

322 KIR AND HLA LOCI AS PREDICTORS OF HCC OUTCOME IN PATIENTS WITH HCV INFECTION

✍ Scribed by Cariani, E.; Pilli, M.; Zerbini, A.; Rota, C.; Olivani, A.; Zanelli, P.; Zanetti, A.; Trenti, T.; Ferrari, C.; Missale, G.

Book ID: 122440512
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 75 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)60324-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1894 Therapeutical aspects and predicto

P1894 Therapeutical aspects and predictors of outcome for HIV/HCV co–infected patients treated with pegylated inter–feron plus ribavirin. Survey in an Italian university hospital

✍ Righi, E.; Bassetti, M.; Di Biagio, A.; Dentone, C.; Rosso, R.; Beltrame, A.; Ma 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A matched case-controlled study of 48 an

A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response

✍ Norio Akuta; Fumitaka Suzuki; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract Substitution of amino acid (aa) 70 and 91 in the core region of HCV genotype 1b is a useful pretreatment predictor of efficacy of 48‐week peginterferon (PEG‐IFN) plus ribavirin (RBV) therapy. Here, we determined the efficacy of 72‐week PEG‐IFN/RBV and the predictive factors to such ther